Clinical Trial Update: Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 chronic dosing cross-over trial evaluating glycopyrronium (PT001) for efficacy and safety in adults with intermittent or mild to moderate persistent ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Glycopyrronium (PT001) (glycopyrronium)

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02